NEW YORK (GenomeWeb) – LGC today announced it has reached a deal to acquire Biosearch Technologies for an undisclosed amount. 

Based in Petaluma, Calif., Biosearch manufactures and supplies custom oligonucleotides and associated reagents to the medical diagnostics, research, and applied markets. Its products are used in molecular diagnostics and the applied and research sectors of the genomics space, LGC said, adding that Biosearch works with the world's top 12 molecular diagnostics firms. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.